---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-054940"
form_type: "8-K"
ticker: "MRKR"
cik: "0001094038"
company_name: "Marker Therapeutics, Inc."
filed_at: "2026-05-04T23:59:59+00:00"
generated_at: "2026-05-14T23:49:23.006117+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Marker Therapeutics shareholders approve increase in authorized shares from 30M to 130M

## Summary
- Shareholders approved Charter Amendment to increase authorized common stock from 30M to 130M shares (10.9M for, 1.4M against).
- Proposal to revise voting threshold for share changes failed; broker non-votes prevented passage.
- All five director nominees re-elected; advisory vote on executive compensation passed.
- Ratification of CBIZ CPAs as independent auditor for fiscal 2026 approved by shareholders.

## SEC filing metadata
- accession: 0001104659-26-054940
- form_type: 8-K
- ticker: MRKR
- cik: 0001094038
- company_name: Marker Therapeutics, Inc.
- filed_at: 2026-05-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1094038/000110465926054940/0001104659-26-054940-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1094038/000110465926054940/tm2613511d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-054940
- JSON: https://secwatch.observer/filing/0001104659-26-054940.json
- Plain text: https://secwatch.observer/filing/0001104659-26-054940.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.